StonvexLoading…
StonvexCore line items from LNTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $368.74M | $377.33M | $1.54B | $1.13B | $750.81M |
Operating Income | Not available | $81.33M | $310.83M | $233.65M | $190.03M |
Net Income | Not available | $118.42M | $233.56M | $179.47M | $78.75M |
EPS (Diluted) | $1.32 | $1.80 | $3.41 | $2.60 | $2.14 |
Total Assets | Not available | $2.35B | $2.23B | $2.28B | $2.12B |
Total Liabilities | Not available | $1.13B | $1.14B | $1.16B | $949.29M |
Cash & Equivalents | Not available | $498.58M | $359.12M | $382.01M | $695.57M |
Free Cash Flow OCF − CapEx | Not available | $121.90M | $354.05M | $272.66M | $177.99M |
Shares Outstanding | Not available | 65.07M | 64.59M | 71.77M | 71.70M |